| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |